AST SpaceMobile stock rebounds after Scotiabank downgrade — what’s next for ASTS
8 January 2026
1 min read

AST SpaceMobile stock rebounds after Scotiabank downgrade — what’s next for ASTS

New York, January 8, 2026, 12:43 PM EST — Regular session

  • AST SpaceMobile shares rose about 6% in midday trade after closing at $85.73 a day earlier.
  • Scotiabank cut its rating and kept a $45.60 target, pointing to valuation and execution risks.
  • Focus turns to launch cadence, customer traction and the next earnings update.

AST SpaceMobile (ASTS) shares were up 5.9% at $90.75 in midday trading on Thursday, after swinging between $85.11 and $93.96. The stock ended Wednesday at $85.73.

The bounce follows a sharp jolt in a stock that has been a standout winner. ASTS fell 12% on Wednesday after a Scotiabank downgrade reignited valuation worries, and the shares traded as low as $83.91 in the session, Barron’s reported. The stock was still up about 304% over the past 12 months, and Barron’s said the company is not expected to turn profitable until 2027. 1

Scotiabank analyst Andres Coello cut the shares to Underperform from Sector Perform and reiterated a $45.60 price target — the level analysts use to signal where they think a stock could trade. Coello said the shares had reached “irrational levels” and flagged questions around timing, user adoption and the cost of building out the constellation, TipRanks reported. 2

AST SpaceMobile is developing satellites designed to connect directly with standard, unmodified smartphones, extending coverage where cell towers do not reach. In a late-December launch update, CEO Abel Avellan called BlueBird 6 a “breakthrough moment” and said the company was targeting 45–60 satellites in orbit by the end of 2026. 3

For investors, the near-term debate is less about the concept — satellite-to-phone service is no longer theoretical — and more about execution. Any signs that carrier trials are converting into paying users, and at what price points, will matter as much as the next launch.

But the downside case is plain: a slip in launch cadence, slower-than-expected uptake, or a higher funding bill than the market is pricing could stretch timelines and keep losses wider for longer. With a stock that has run hard, that kind of delay can hit fast.

ASTS’s next scheduled milestone for many traders is its next earnings report, which Nasdaq lists as estimated for March 2, 2026, when investors will be looking for an update on cash use, deployment pace and commercial readiness. 4

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026
Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
Mastercard stock climbs as Apple taps JPMorgan for Apple Card, keeps Mastercard network
Previous Story

Mastercard stock climbs as Apple taps JPMorgan for Apple Card, keeps Mastercard network

Caesars Entertainment stock jumps nearly 9% after Susquehanna upgrade — what investors watch next
Next Story

Caesars Entertainment stock jumps nearly 9% after Susquehanna upgrade — what investors watch next

Go toTop